Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The US Food and Drug Administration has approved several medications for obesity management, with clinical guidelines recommending pharmacologic treatment as a part of a comprehensive strategy for disease management among individuals with a BMI of 2729.9 kg/m 2 and 1 obesity-related complication or with a BMI 30 kg/m 2 [8, 9]
A lower dose than expected is unlikely to have side effects
Other GLP-1 drugs can help OSA indirectly through weight loss, but only tirzepatide carries an OSA indication
Crucially, many trials may have included older adults, but had an upper age limit in their inclusion/exclusion criteria, resulting in little data for people in their 80s
US$ 21.81
US$ 28.79
US$ 23.16
US$ 21.67
US$ 29.48
US$ 24.74
